Significant decline in the erythromycin resistance of group A streptococcus isolates at a German paediatric tertiary care centre

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 5, 2012, Pages 707-710

  Farmand, S ^a   Henneke, P ^a   Hufnagel, M ^a   Berner, R ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFOTAXIME; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; ERMB GENE; ERMTR GENE; GERMANY; MEFA GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; PRTF1 GENE; STREPTOCOCCUS GROUP A; TERTIARY HEALTH CARE;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CHILD; CHILD, PRESCHOOL; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; FEMALE; GENES, BACTERIAL; GERMANY; HUMANS; INFANT; MACROLIDES; MALE; PREVALENCE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 84862846022     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1362-3     Document Type: Article

References (19)

1. Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH; Infectious Diseases Society of America (2002) Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis 35: 113-125
2. Liu X, Shen X, Chang H, Huang G, Fu Z, Zheng Y, Wang L, Li C, Liu L, Shen Y, Yang Y (2009) High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China. Pediatr Pulmonol 44 (5): 436-441
3. Clancy J, Petitpas J, Dib-Hajj F, Yuan W, Cronan M, Kamath AV, Bergeron J, Retsema JA (1996) Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol Microbiol 22 (5): 867-879
4. Leclercq R, Courvalin P (1991) Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob Agents Chemother 35 (7): 1267-1272
5. Seppälä H, Skurnik M, Soini H, Roberts MC, Huovinen P (1998) A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob Agents Chemother 42 (2): 257-262
6. Facinelli B, Spinaci C, Magi G, Giovanetti E, Varaldo PE (2001) Association between erythromycin resistance and ability to enter human respiratory cells in group A streptococci. Lancet 358: 30-33
7. Haller M, Fluegge K, Arri SJ, Adams B, Berner R (2005) Association between resistance to erythromycin and the presence of the fibronectin binding protein F1 gene, prtF1, in Streptococcus pyogenes isolates from German pediatric patients. Antimicrob Agents Chemother 49 (7): 2990-2993
8. NICE Short Clinical Guidelines Technical Team (2008) Respiratory tract infections-antibiotic prescribing. Prescribing of antibiotics for self-limiting respiratory tract infections in adults and children in primary care. National Institute for Health and Clinical Excellence, London
9. Bingen E, Fitoussi F, Doit C, Cohen R, Tanna A, George R, Loukil C, Brahimi N, Le Thomas I, Deforche D (2000) Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients. Antimicrob Agents Chemother 44 (6): 1453-1457
10. Fluegge K, Supper S, Siedler A, Berner R (2004) Antibiotic susceptibility in neonatal invasive isolates of Streptococcus agalactiae in a 2-year nationwide surveillance study in Germany. Antimicrob Agents Chemother 48 (11): 4444-4446
11. Neeman R, Keller N, Barzilai A, Korenman Z, Sela S (1998) Prevalence of internalisation-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers. Lancet 352 (9145): 1974-1977
12. Cantón R, Loza E, Morosini MI, Baquero F (2002) Antimicrobial resistance amongst isolates of Streptococcus pyogenes and Staphylococcus aureus in the PROTEKT antimicrobial surveillance programme during 1999-2000. J Antimicrob Chemother 50 (Suppl S1): 9-24
13. van der Linden M, Imöhl M, Reinert RR (2008) 4.1.1 Streptococcus spp. 4.1.1.1 Streptococcus pyogenes. In: GERMAP 2008. Antibiotika-Resistenz und-Verbrauch. ISBN 978-3-00-025097-2, p. 29
14. Seppälä H, Klaukka T, Lehtonen R, Nenonen E, Huovinen P (1995) Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clin Infect Dis 21 (6): 1378-1385
15. Malhotra-Kumar S, Lammens C, Coenen S, Van Herck K, Goossens H (2007) Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebocontrolled study. Lancet 369 (9560): 482-490
16. Zavadska D, Berziņa D, Drukaļska L, Pugacova N, Miklasevics E, Gardovska D (2010) Macrolide resistance in group A beta haemolytic Streptococcus isolated from outpatient children in Latvia. APMIS 118 (5): 366-370
17. Kern WV, Schröder H (2008) 2.1 Antibiotikaverbrauch im ambulanten Bereich. In: GERMAP 2008. Antibiotika-Resistenz und-Verbrauch. ISBN 978-3-00-025097-2, p. 15
18. Malli E, Tatsidou E, Damani A, Pantelidi K, Petinaki E, Skoulakis C, Drougka E, Spiliopoulou I (2010) Macrolide-resistant Streptococcus pyogenes in Central Greece: prevalence; mechanism and molecular identification. Int J Antimicrob Agents 35 (6): 614-615
19. Green M, Martin JM, Barbadora KA, Beall B, Wald ER (2004) Reemergence of macrolide resistance in pharyngeal isolates of group A streptococci in southwestern Pennsylvania. Antimicrob Agents Chemother 48 (2): 473-476